跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,330 条关于
“Yangzhou Shizhiyuan Biotechnology”
全部
5,330
临床试验
54
药物
870
机构
313
资讯
4,093
昨天
Shanghai Shen Lian's UB-221 Meets Primary Endpoint in Phase II Clinical Trial
去年
Alebund Pharmaceuticals Completes Series C Financing of RMB 550 Million
9个月前
Puma Biotechnology Joins NASDAQ Biotechnology Index Following Commercial Success and Clinical Progress
2个月前
Oman Moves Closer to Adopting National Biotechnology Strategy
2年前
Vir Biotechnology's HDV Therapy Receives FDA Breakthrough Therapy Designation
6年前
First In Vivo CRISPR Therapy Dosed in Clinical Trial for Congenital Blindness
4个月前
LQR House Partners with Hangzhou GSY Biotechnology to Develop Functional Wellness Beverages Using Proprietary Fermentation Technology
去年
PDS Biotechnology Secures $11 Million in Latest Funding Round
去年
Glucose-Responsive Insulin Analog Shows Promise in Reducing Hypoglycemia Risk
去年
AAV Vector Production Challenges Drive Innovation in Gene Therapy Manufacturing
第 1 页，共 410 页
上一页
下一页
